Floatz logo

Pentoxifylline

Metabolic Dysfunction-Associated Steatohepatitis

Al-Azhar UniversitySmall moleculePhase 4 / ApprovedActive
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
68/ 100
Competitive Position
89/ 100

Competitive context

127 Active assets in the Metabolic Dysfunction-Associated Steatohepatitis cohort.

Asset / SponsorPhaseRating
Resmetirom
City University of New York
Phase 4BBB
Pioglitazone
Badr University
Phase 4BBB
Firsocostat
Gilead Sciences
Phase 2BBB
Alpha Tocopherol
Shanghai Jiao Tong University School of Medicine
Phase 4BBB
Rosuvastatin
Beni-Suef University
Phase 4BBB

View all 50 →

Same molecule, other indications

Pentoxifylline is also rated in:

type 2 diabetes mellitusDormant
BB
Indicative · Phase 4
68 / 100
View asset →
peripheral neuropathyActive
BB
Indicative · Phase 2/3
66 / 100
View asset →
colorectal carcinomaActive
BB
Indicative · Phase 4
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →